Letter: mucosal response in discriminating intestinal tuberculosis from Crohn's disease-when to look for it?

Global surgical landscape and outcomes in Crohn's disease in the biologics era: a systematic review protocol.

BMJ open·2026

Top-down versus step-up approach after endoscopic ultrasound-guided drainage of infected walled-off necrosis: a randomized controlled trial.

Endoscopy·2026

Clostridioides difficile infection in inflammatory bowel disease: an observational study in flares of ulcerative colitis and a South Asian region-specific systematic review and meta-analysis.

Therapeutic advances in gastroenterology·2026

Caregiver burden in inflammatory bowel disease: a systematic review and meta-analysis.

BMC psychology·2026

Rethinking the dose: A Bayesian meta-analysis of infliximab intensification in acute severe ulcerative colitis.

Inflammatory bowel diseases·2026

Review Article: TL1A Inhibitors in IBD - Mechanistic Rationale and Clinical Evidence.

Alimentary pharmacology & therapeutics·2026

Carriage of the Laboratory of Genetics and Physiology Protein 2 Q425R Variant Reduces Liver Disease Severity in European Patients With Chronic Hepatitis Delta.

Alimentary pharmacology & therapeutics·2026

Clinical Trial: Randomised Placebo-Controlled Trial of Methylcellulose and Psyllium Gels on Inulin-Induced Colonic Gas.

Alimentary pharmacology & therapeutics·2026

HLA-A*11:01 Identifies Patients at Risk for Persistent Viraemia and Advanced Fibrosis in HDV Infection.

Alimentary pharmacology & therapeutics·2026

Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease-A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).

Alimentary pharmacology & therapeutics·2026

Risk of Coeliac Disease After Immune Checkpoint Inhibitor Exposure in Patients With Cancer.

Alimentary pharmacology & therapeutics·2026

Pharmacokinetic and Pharmacodynamic Variability Predict Late Events After Paediatric Liver Transplantation: Derivation and External Validation of a Landmark Risk Score.

Alimentary pharmacology & therapeutics·2026

VirPLM: Antigenic prediction of influenza A/H3N2 viruses with a fine-tuned protein language model.

Bioinformatics (Oxford, England)·2026

Mechanism of IH promoting pulmonary arterial hypertension through ROS-NLRP3 inflammasome mediated endothelial cell pyroptosis.

Experimental lung research·2026

IgE-Binding Bacterial Components Not Yet Documented in the Allergen Databases and Their Allergenic Mechanisms: An EAACI Position Paper.

Allergy·2026

Multifocal mucocutaneous herpes simplex virus type 1 infection temporally associated with seasonal influenza vaccination in a young adult without a known immunocompromising condition: A case report.

Human vaccines & immunotherapeutics·2026

ILC3s as central regulators of mucosal homeostasis and disease pathogenesis (Review).

International journal of molecular medicine·2026

Related Experiment Videos

Letter: mucosal response in discriminating intestinal tuberculosis from Crohn's disease-when to look for it?

Related Concept Videos

Global surgical landscape and outcomes in Crohn's disease in the biologics era: a systematic review protocol.

Top-down versus step-up approach after endoscopic ultrasound-guided drainage of infected walled-off necrosis: a randomized controlled trial.

Clostridioides difficile infection in inflammatory bowel disease: an observational study in flares of ulcerative colitis and a South Asian region-specific systematic review and meta-analysis.

Caregiver burden in inflammatory bowel disease: a systematic review and meta-analysis.

Rethinking the dose: A Bayesian meta-analysis of infliximab intensification in acute severe ulcerative colitis.

Review Article: TL1A Inhibitors in IBD - Mechanistic Rationale and Clinical Evidence.

Carriage of the Laboratory of Genetics and Physiology Protein 2 Q425R Variant Reduces Liver Disease Severity in European Patients With Chronic Hepatitis Delta.

Clinical Trial: Randomised Placebo-Controlled Trial of Methylcellulose and Psyllium Gels on Inulin-Induced Colonic Gas.

HLA-A*11:01 Identifies Patients at Risk for Persistent Viraemia and Advanced Fibrosis in HDV Infection.

Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease-A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).

Risk of Coeliac Disease After Immune Checkpoint Inhibitor Exposure in Patients With Cancer.

Pharmacokinetic and Pharmacodynamic Variability Predict Late Events After Paediatric Liver Transplantation: Derivation and External Validation of a Landmark Risk Score.

VirPLM: Antigenic prediction of influenza A/H3N2 viruses with a fine-tuned protein language model.

Mechanism of IH promoting pulmonary arterial hypertension through ROS-NLRP3 inflammasome mediated endothelial cell pyroptosis.

IgE-Binding Bacterial Components Not Yet Documented in the Allergen Databases and Their Allergenic Mechanisms: An EAACI Position Paper.

Multifocal mucocutaneous herpes simplex virus type 1 infection temporally associated with seasonal influenza vaccination in a young adult without a known immunocompromising condition: A case report.

ILC3s as central regulators of mucosal homeostasis and disease pathogenesis (Review).

Related Experiment Videos

Letter: mucosal response in discriminating intestinal tuberculosis from Crohn's disease-when to look for it?

Related Concept Videos

Related Articles